Feb 25, 2021
Provention Bio Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Feb 17, 2021
Provention Bio and Huadong Announce Strategic Collaboration to Develop and Commercialize PRV-3279 in Greater China
Jan 28, 2021
Provention Bio Announces Key Findings from Pre-clinical Proof-of-concept Study for PRV-3279 for the Prevention of Immunogenicity of Gene Therapy
Jan 12, 2021
Provention Bio Announces Proposed Public Offering of Common Stock
Jan 06, 2021
Provention Bio to Participate in the H.C. Wainwright Virtual BioConnect Conference
Dec 21, 2020
Provention Bio Announces Addition to NASDAQ Biotechnology Index
Nov 11, 2020
Provention Bio to Present at the Stifel Virtual Healthcare Conference
Nov 05, 2020
Provention Bio Reports Third Quarter 2020 Financial Results and Provides Business Update
Nov 02, 2020
Provention Bio Completes Rolling Submission of the Biologics License Application (BLA) for Teplizumab for the Delay or Prevention of Clinical Type 1 Diabetes in At-risk Individuals
Oct 01, 2020
Provention Bio Announces National Effort to Redefine Patient Care in Type 1 Diabetes (T1D)
Sep 30, 2020
Provention Bio Files Clinical Module for Teplizumab for the Delay or Prevention of Clinical Type 1 Diabetes in At-Risk Individuals
Sep 08, 2020
Provention Bio to Present at Upcoming Virtual Investor Conferences
Aug 25, 2020
AGC Biologics Completes PPQ Manufacturing Campaign with Provention Bio for Type 1 Diabetes Product Candidate, Teplizumab
Aug 11, 2020
John K. Jenkins, MD Joins Provention Bio Board of Directors
Aug 06, 2020
Provention Bio Reports Second Quarter 2020 Financial Results and Provides Business Update
Jul 30, 2020
Provention Bio to Report Second Quarter 2020 Financial Results and Host Conference Call on Thursday, August 6, 2020
Jun 29, 2020
Provention Bio Announces Inclusion in the Russell 3000 Index and Russell 2000 Index
Jun 16, 2020
Provention Bio Announces Proposed Public Offering of Common Stock
Jun 15, 2020
Provention Bio's Teplizumab Continued to Significantly Delay the Onset of Insulin-Dependent Type 1 Diabetes (T1D) in Presymptomatic Patients
May 28, 2020
Provention Bio to Present at the Jefferies Virtual Healthcare Conference